Huang W - Search Results

1

Predictors of sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma.

Yi Y, Li B, Sun H, Zhang Z, Gong H, Li H, Huang W, Wang Z. Yi Y, et al. Among authors: huang w. Tumour Biol. 2010 Aug;31(4):333-40. doi: 10.1007/s13277-010-0041-9. Epub 2010 May 20. Tumour Biol. 2010. PMID: 20490963

2

[Impact of the pattern of lymph node metastasis on the clinical target volume in radiotherapy for thoracic esophageal squamous cell carcinoma].

Huang W, Li BS, Gong HY, Fan M, Sun HF, Zhou T, Liu XB. Huang W, et al. Zhonghua Zhong Liu Za Zhi. 2010 Mar;32(3):225-8. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20450594 Chinese.

3

Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume delineation of regional lymph node in patients with gastric carcinoma.

Yi Y, Yu J, Li B, Yang F, Huang W, Sun H, Gong H, Zhou T, Lin H. Yi Y, et al. Among authors: huang w. Radiother Oncol. 2010 Aug;96(2):223-30. doi: 10.1016/j.radonc.2010.04.031. Epub 2010 Jun 30. Radiother Oncol. 2010. PMID: 20584555

4

CYFRA21-1 can predict the sensitivity to chemoradiotherapy of non-small-cell lung carcinoma.

Wang J, Yi Y, Li B, Wang Z, Sun H, Zhang P, Huang W. Wang J, et al. Among authors: huang w. Biomarkers. 2010 Nov;15(7):594-601. doi: 10.3109/1354750X.2010.504308. Epub 2010 Jul 23. Biomarkers. 2010. PMID: 20649505

5

Decline of serum CYFRA21-1 during chemoradiotherapy of NSCLC: a probable predictive factor for tumor response.

Wang J, Zhang N, Li B, Wang Z, Sun H, Yi Y, Huang W. Wang J, et al. Among authors: huang w. Tumour Biol. 2011 Aug;32(4):689-95. doi: 10.1007/s13277-011-0169-2. Epub 2011 Mar 16. Tumour Biol. 2011. PMID: 21409421

6

Phase I study of pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced non-small cell lung cancer.

Li BS, Gong HY, Huang W, Yi Y, Yu JM, Wang ZT, Zhang ZC, Sun HF, Li HS, Wang LY. Li BS, et al. Among authors: huang w. Am J Clin Oncol. 2012 Apr;35(2):115-9. doi: 10.1097/COC.0b013e318209ab93. Am J Clin Oncol. 2012. PMID: 21555933 Clinical Trial.

7

Explore the radiotherapeutic clinical target volume delineation for thoracic esophageal squamous cell carcinoma from the pattern of lymphatic metastases.

Cheng J, Kong L, Huang W, Li B, Li H, Wang Z, Zhang J, Zhou T, Sun H. Cheng J, et al. Among authors: huang w. J Thorac Oncol. 2013 Mar;8(3):359-65. doi: 10.1097/JTO.0b013e31827e1f6d. J Thorac Oncol. 2013. PMID: 23263689 Free article.

8

Standard uptake value and metabolic tumor volume of ¹⁸F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer.

Huang W, Zhou T, Ma L, Sun H, Gong H, Wang J, Yu J, Li B. Huang W, et al. Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1628-35. doi: 10.1007/s00259-011-1838-5. Epub 2011 May 27. Eur J Nucl Med Mol Imaging. 2011. PMID: 21617977 Clinical Trial.

9

Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis.

Zhang J, Yang F, Li B, Li H, Liu J, Huang W, Wang D, Yi Y, Wang J. Zhang J, et al. Among authors: huang w. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e305-16. doi: 10.1016/j.ijrobp.2011.04.034. Epub 2011 Jun 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 21658853 Review.

10

[Role of (18)F-FDG PET for therapeutic monitoring in non-small-cell lung cancer].

Huang W, Wang J, Li BS. Huang W, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2010 Nov;33(11):855-7. Zhonghua Jie He He Hu Xi Za Zhi. 2010. PMID: 21211376 Review. Chinese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,349 results

Search Page

Filters